U.S. Court of Appeals for the Federal Circuit
Dr. Falk Pharma Gmbh v. Generico, LLC
This writing
- Type
- Opinion
- Filed
- Feb. 8, 2019
- Case
- Dr. Falk Pharma Gmbh v. Generico, LLC
- Case status
- Decided
Source No authoring judge could be established for this writing, either from provider metadata or from the signature line of the court's published opinion. Benchlight shows the gap rather than guessing at an author.
Opening text
The first passage of the document, as extracted by the source provider.
O'Malley, Circuit Judge. ORDER At issue are three motions to disqualify Katten Muchin Rosenman LLP as counsel for Mylan Pharmaceuticals Inc. ("Mylan") in three appeals before this court. Valeant Pharmaceuticals International, Inc. ("Valeant-CA") and Salix Pharmaceuticals, Inc. ("Salix") move to disqualify in Valeant Pharmaceuticals…
Source Extract supplied by CourtListener. Benchlight does not host the document — read the authoritative text in the court's own PDF.